Company / SG&A per Share
Xenon Pharmaceuticals Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.00
FY2025
5-year range
$0.50 / $1.00
FY2021-FY2025
Trend
+13.6%
vs FY2024
Sector context
#121 of 210
Health Care
What the data says
At $1.00, Xenon Pharmaceuticals Inc.'s sg&a per share ranks #90 of 210 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $0.37 in FY2020 to $1.00 in FY2025.
Based on SEC 10-K filings.
1.00 in FY2025 with a 5-year CAGR of +21.8%.
Increased from $0.70 to $1.00 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +22.8%
- 5-Year CAGR
- +21.8%
- 10-Year CAGR
- -
Sector benchmark
#90 of 210 in Health CareTop 42% of 210This company $1.00 Sector average $40.75
▼
-97.5% below sector average
Key checks
Key Insights
- Xenon Pharmaceuticals Inc.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 13.6% year-over-year.
- Ranks #121 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.00 | +13.6% |
| FY2024 | $0.88 | +27.1% |
| FY2023 | $0.70 | +28.4% |
| FY2022 | $0.54 | +7.6% |
| FY2021 | $0.50 | +34.4% |
| FY2020 | $0.37 | -10.0% |
| FY2019 | $0.42 | -10.8% |
| FY2018 | $0.47 | -14.4% |
| FY2017 | $0.55 | +15.6% |
| FY2016 | $0.47 | -31.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026